The Global Medicines Program improves the access, use, safety, quality, cost-effectiveness, and affordability of medicines in lower income countries by generating and disseminating new methods and knowledge on medicine safety and value, teaching and mentoring trainees, and strengthening pharmaceutical systems and services.
The Program was established in 2010 as a partnership between the UW Department of Global Health and the School of Pharmacy. Our activities include:
The following courses are offered at the UW:
- PHARM 581/GH 543: Global Health Pharmacy: Medicines, Practice, and Policy, Winter Quarters.
- PHARM 582/GH 590-I: Special Topics in Global Health Pharmacy and Medical Products, Spring Quarters.
We mentor graduate (MS and PhD) and professional degree (e.g., PharmD) students in medicines safety and value.
We conduct research on the safety and post-market surveillance of medicines, including vaccines, and perform economic evaluations of medicines, other health technologies, and pharmacy-based services.
Examples of our research include developing innovative approaches to monitor the safety of antimalarial drug use during pregnancy; active surveillance of the safety of HIV/AIDS medicines; impact evaluations of supply chain strengthening; cost-effectiveness of vaccines; pharmacoeconomics of HIV prevention.
Capacity Building and Global Outreach
We assist with strengthening pharmaceutical systems in low- and middle-income countries by providing in-country trainings and other types of technical assistance. These activities strengthen pharmacovigilance programs and pharmaceutical care services and improve in-country capacity for health technology assessment and cost-effectiveness analyses.
To learn more about the Global Medicines Program, please visit our website at www.globalmedicines.org